Research
Find research shared by the Owlstown community.
Does Phase-Contrast Imaging through the Cerebral Aqueduct Predict the Outcome of Lumbar CSF Drainage or Shunt Surgery in Patients with Suspected Adult Hydrocephalus?
Abstract
In this retrospective study, the phase-contrast MR imaging of 185 patients with suspected chronic adult hydrocephalus was evaluated using the CSF Flow software package. Decision-making for shunt placement was performed in this cohort on...
Publication · February 01, 2026
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease
Publication · February 01, 2026
Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years
Publication · February 01, 2026
THE CONTRIBUTION OF SEX-SPECIFIC ASSOCIATIONS IN GENETIC STUDIES OF ALZHEIMER’S DISEASE PATHOLOGY
Publication · February 01, 2026
Does the Presence or Absence of DESH Predict Outcomes in Adult Hydrocephalus?
Abstract
BACKGROUND AND PURPOSE: The DESH (disproportionately enlarged subarachnoid-space hydrocephalus) pattern of “tight high-convexity and medial subarachnoid spaces, and enlarged Sylvian fissures with ventriculomegaly” is used to determine w...
Publication · February 01, 2026
Single-Element Needle-Based Ultrasound Imaging of the Spine: An In Vivo Feasibility Study
Publication · February 01, 2026
Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects
Abstract
11C-RO-963, 11C-RO-643, and 18F-RO-948 (previously referred to as 11C-RO6924963, 11C-RO6931643, and 18F-RO6958948, respectively) have been reported as promising PET tracers for tau imaging based on in vitro and preclinical PET data. Her...
Publication · February 01, 2026
Non‐contrast MR imaging of blood‐brain barrier permeability to water
Publication · February 01, 2026
Identifying Changepoints in Biomarkers During the Preclinical Phase of AD
Abstract
Objective Several models have been proposed for the evolution of Alzheimer’s disease (AD) biomarkers. The aim of this study was to identify changepoints in a range of biomarkers during the preclinical phase of AD. Methods We examined ni...
Publication · February 01, 2026